论文部分内容阅读
目的探讨联合用药治疗内分泌失调性不孕的临床效果。方法 80例内分泌失调性不孕患者进行绒毛膜促性腺激素(HCG)、克罗米芬(CC)以及人绝经促性腺激素(HMG)联合治疗,一段时间后观察患者的治疗效果并对其加以分析。结果 80例患者接受了148个治疗周期的联合用药后,有123个周期出现了排卵的现象,排卵成功率为83.10%,能够成功妊娠的有62例,妊娠率达到了77.5%。结论联合用药治疗内分泌失调性不孕在临床上有着非常好的效果,能够显著地提高排卵率和成功妊娠率。结果显示,联合用药治疗内分泌失调性不孕疗效显著,值得推广。
Objective To investigate the clinical effect of combination therapy on endocrine disorders infertility. Methods Eighty patients with endocrine disorders infertility were treated with HCG, clomiphene citrate (CC) and human menoprogenical gonadotropin (HMG). The therapeutic effect was observed and analyzed after a period of time. Results 80 patients received 148 cycles of combination therapy, there are 123 cycles of ovulation occurred, the success rate of ovulation was 83.10%, 62 cases of successful pregnancy, the pregnancy rate reached 77.5%. Conclusion Combined treatment of endocrine disorders infertility has a very good clinical effect, can significantly improve the ovulation rate and successful pregnancy rate. The results show that combination therapy for endocrine disorders infertility significant effect, it is worth promoting.